Crk II silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cells

Pooja Dhupkar, Huang Zhao, Kalpana Mujoo, Zhiqiang An, Ningyan Zhang

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Crk (C10 regulator of kinase) adaptor proteins are highly expressed in many types of human cancers and often contribute to aggressive cancer phenotypes. Crk II, a member of CRK family, has been reported to regulate cell migration and metastasis in breast cancer cells. However, its role in other cancer types has not been reported. In this study, we investigated the molecular function of Crk II in prostate cancer (PCa) cells (CWR-22rv1) in vitro and using a mouse tumor model. Results showed that Crk II knockdown by shRNA-mediated silencing (Crk II-shRNA) in the PCa cells significantly inhibited both cancer cell migration and invasion in cell culture study. Crk II-shRNA cancer cells also significantly decreased colony formation in vitro, but had no significant reduction of tumor volume after 4 weeks of cancer cell xenografting in vivo when compared to the scramble control. Interestingly, Crk II-shRNA cancer cells showed a greatly reduced level of insulin-like growth factor 1 receptor (IGF-1R) and decreased signaling of the IGF-1R/PI3K/Akt axis upon IGF-1 ligand stimulation. A close interaction between Crk II and IGF-1R was demonstrated upon co-immunoprecipitation of IGF-1R with Crk II protein. Further, treatment of cells with either proteosomal degradation or protein synthesis inhibitor showed higher proportion of ubiquitin-associated IGF-1R and faster degradation of IGF-1R in Crk II-shRNA cells in comparison with that in the control cancer cells. Taken together, these data suggest that Crk II plays an important role in the regulation of IGF-1R protein stability and affects downstream of IGF-1R signaling pathways. Therefore, targeting Crk-II can block IGF-1R growth signaling and suppress cancer cell invasion and progression.

Original languageEnglish (US)
Pages (from-to)382-388
Number of pages7
JournalBiochemistry and Biophysics Reports
StatePublished - Dec 1 2016


  • Crk II
  • IGF-1R
  • Prostate cancer

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry


Dive into the research topics of 'Crk II silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cells'. Together they form a unique fingerprint.

Cite this